ETC
TAK icon

Exchange Traded Concepts’s Takeda Pharmaceutical TAK Stock Holding History

Exchange Traded Concepts’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-59,201
Closed -$880K – 1502
2025
Q1 		$880K Sell
59,201
-2,299
-4% -$32.2K 0.02% 604
2024
Q4 		$814K Sell
61,500
-1,971
-3% -$27.1K 0.02% 649
2024
Q3 		$903K Buy
63,471
+27,756
+78% +$394K 0.02% 555
2024
Q2 		$462K Buy
+35,715
New +$473K 0.01% 714

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Exchange Traded Concepts's TAK Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Takeda Pharmaceutical (TAK) in Q2 2025, closing a stake of 59,201 shares — an estimated $880K sold.

Exchange Traded Concepts first reported a position in TAK in Q2 2024 and held it in 4 quarters. The position peaked at $903K in Q3 2024. 315 funds tracked by Wall St. Rank hold TAK as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Takeda Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 59,201 Takeda Pharmaceutical shares in Q2 2025, an estimated $880K.
  • Exchange Traded Concepts first reported a position in Takeda Pharmaceutical in Q2 2024 and held it in 4 quarters.
  • Exchange Traded Concepts's Takeda Pharmaceutical position peaked at $903K in Q3 2024.
  • 315 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.